Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence

被引:1
作者
Orji, Foster Tochukwu [1 ]
Akpeh, James O. [2 ]
Okolugbo, Nekwu E. [3 ]
机构
[1] Univ Nigeria Nsukka, Dept Otolaryngol, Enugu, Nigeria
[2] Univ Nigeria Teaching Hosp, Enugu, Nigeria
[3] Delta State Univ, Dept Surg, Abraka, Nigeria
关键词
Coronavirus; COVID-19; Olfactory dysfunction; Anosmia; Hyposmia; Recovery; CORONAVIRUS;
D O I
10.1007/s12070-023-04005-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Recently acquired olfactory dysfunction (OD) has emerged as one of hallmark manifestations of the novel Corona virus disease (COVID-19), but the evolution of its spontaneous recovery has remained inconclusive, with reports of persistence of OD beyond six months of onset. We undertook this systematic review and meta-analysis with a view to generating a pooled recovery rate of COVID-19 associated olfactory dysfunctions and attempt to examine the predictors of olfactory recovery. Systematic review and meta-analysis. A systematic search of Scopus, Google Scholar, and PubMed data bases, comprising all longitudinal studies reporting the trajectory of COVID-19 related OD was carried out. The pooled recovery rate was estimated with random-effects model, and the potential heterogeneity of the subgroup sources was analyzed using meta-regression test. After the PRISMA selection process 28 studies from 16 countries were included, with a total of 5,175 OD patients, among 11,948 COVID-19 cases. The estimated global pooled recovery rate of OD was 82.7% (95% CI, 77.46%-88.04%), with a pooled median duration of OD of 11.6 days. Only 2 out of 28 studies had recovery data beyond a period of 2 months. But no significant difference was found in the recovery rate regarding the length of follow up (P = 0.840). Studies that conducted objective olfactory assessments showed significant higher recovery rate than those with subjective assessments (P = 0.001). Although ten studies (36%) reported > 90% recovery, nine studies (32%) documented persistence of OD in > 25% of their patients. Five out of 6 studies showed that hyposmia tended to show complete recovery than anosmia. Age, co-morbidities, and intra-nasal treatments had no effects. Test of homogeneity between subgroups using the Cochran's Q test was not significant (Q = 0.69, P = 0.40). Our meta-analysis revealed high rate of early and medium term recovery of COVID-19 related OD. However, it also showed disturbing rates of persistence of OD. Anosmia tended to be predictive of residual OD than hyposmia. Age, co-morbidities, intra-nasal corticosteroid and decongestants, had no effects on OD recovery.
引用
收藏
页码:4179 / 4189
页数:11
相关论文
共 46 条
  • [1] Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial
    Abdelalim, Abdelrahman Ahmed
    Mohamady, Ayman Abdelaal
    Elsayed, Rasha Abdelhamid
    Elawady, Mona Ahmed
    Ghallab, Abdelhakim Fouad
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (02)
  • [2] The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
    Alipoor, Shamila D.
    Mortaz, Esmaeil
    Varahram, Mohammad
    Garssen, Johan
    Adcock, Ian M.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [3] The temporal course of COVID-19 anosmia and relation to other clinical symptoms
    Altundag, Aytug
    Saatci, Ozlem
    Sanli, Deniz Esin Tekcan
    Duz, Ozge Arici
    Sanli, Ahmet Necati
    Olmuscelik, Oktay
    Temirbekov, Dastan
    Kandemirli, Sedat Giray
    Karaaltin, Aysegul Batioglu
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (06) : 1891 - 1897
  • [4] Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study
    Amer, Mohamed A.
    Elsherif, Hossam S.
    Abdel-Hamid, Ahmed S.
    Elzayat, Saad
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2020, 41 (06)
  • [5] Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study
    Beltran-Corbellini, A.
    Chico-Garcia, J. L.
    Martinez-Poles, J.
    Rodriguez-Jorge, F.
    Natera-Villalba, E.
    Gomez-Corral, J.
    Gomez-Lopez, A.
    Monreal, E.
    Parra-Diaz, P.
    Cortes-Cuevas, J. L.
    Galan, J. C.
    Fragola-Arnau, C.
    Porta-Etessam, J.
    Masjuan, J.
    Alonso-Canovas, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (09) : 1738 - 1741
  • [6] Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review
    Boscutti, A.
    Delvecchio, G.
    Pigoni, A.
    Cereda, G.
    Ciappolino, V.
    Bellani, M.
    Fusar-Poli, P.
    Brambilla, P.
    [J]. BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2021, 15
  • [7] Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
    Bousquet, Jean
    Akdis, Cezmi A.
    Jutel, Marek
    Bachert, Claus
    Klimek, Ludger
    Agache, Ioana
    Ansotegui, Ignacio J.
    Bedbrook, Anna
    Bosnic-Anticevich, Sinthia
    Canonica, G. Walter
    Chivato, Tomas
    Cruz, Alvaro A.
    Czarlewski, Wienczyslawa
    Del Giacco, Stefano
    Du, Hui
    Fonseca, Joao A.
    Gao, Yadong
    Haahtela, Tari
    Hoffmann-Sommergruber, Karin
    Ivancevich, Juan-Carlos
    Khaltaev, Nikolai
    Knol, Edward F.
    Kuna, Piotr
    Larenas-Linnemann, Desiree
    Mullol, Joaquim
    Naclerio, Robert
    Ohta, Ken
    Okamoto, Yoshitaka
    O'Mahony, Liam
    Onorato, Gabrielle L.
    Papadopoulos, Nikos G.
    Pfaar, Oliver
    Samolinski, Boleslaw
    Schwarze, Jurgen
    Toppila-Salmi, Sanna
    Ventura, Maria-Teresa
    Valiulis, Arunas
    Yorgancioglu, Arzu
    Zuberbier, Torsten
    Pawankar, Ruby
    [J]. ALLERGY, 2020, 75 (10) : 2440 - 2444
  • [8] Chemosensory Dysfunction in COVID-19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample
    Brandao Neto, Deusdedit
    Fornazieri, Marco Aurelio
    Dib, Caroline
    Di Francesco, Renata Cantisani
    Doty, Richard L.
    Voegels, Richard Louis
    Pinna, Fabio de Rezende
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 164 (03) : 512 - 518
  • [9] Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia
    Brann, David H.
    Tsukahara, Tatsuya
    Weinreb, Caleb
    Lipovsek, Marcela
    Van den Berge, Koen
    Gong, Boying
    Chance, Rebecca
    Macaulay, Iain C.
    Chou, Hsin-Jung
    Fletcher, Russell B.
    Das, Diya
    Street, Kelly
    de Bezieux, Hector Roux
    Choi, Yoon-Gi
    Risso, Davide
    Dudoit, Sandrine
    Purdom, Elizabeth
    Mill, Jonathan
    Hachem, Ralph Abi
    Matsunami, Hiroaki
    Logan, Darren W.
    Goldstein, Bradley J.
    Grubb, Matthew S.
    Ngai, John
    Datta, Sandeep Robert
    [J]. SCIENCE ADVANCES, 2020, 6 (31)
  • [10] Centres for Disease Control and prevention, 2021, COR SELF CHECK